Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center

Comparing clinical characteristics of systemic sclerosis with or without interstitial lung disease: A cross-sectional study from a single center of the Chinese Rheumatism Data Center

BackgroundWe aimed to compare the clinical characteristics of patients with systemic sclerosis (SSc) with or without interstitial lung disease (ILD) to identify relationships with the presence of ILD in SSc at a single center in China.MethodsA cross-sectional study was conducted using retrospective...

Full description

Bibliographic Details
Main Authors:	Haoguang Li, Xiuling Zhang, Le Yu, Jingjing Shang, Jie Fan, Xueqin Feng, Rongwei Zhang, Jie Ren, Qifang Guo, Xinwang Duan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Medicine
Subjects:	systemic sclerosis clinical characteristic interstitial lung disease (ILD) China cross-sectional study
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1061738/full

Similar Items

Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
by: Toshiyuki Sumi, et al.
Published: (2021-03-01)

The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01)

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
by: Rong-Hong Guo, et al.
Published: (2022-11-01)

Nintedanib in systemic sclerosis treatment: a case report
by: Maysoun Kudsi, et al.
Published: (2024-02-01)

Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
by: Matthias Griese, et al.
Published: (2020-04-01)

Hook effect and serum KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
by: Emmy Hermiyanti Pranggono, et al.
Published: (2021-10-01)

Bridges of Pulmonology 2023 proceedings: Highlights in the field of interstitial lung diseases
by: Vasilina Sotiropoulou, et al.
Published: (2024-03-01)

High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
by: Barbara Ruaro, et al.
Published: (2021-12-01)

Childhood interstitial lung disease: When to suspect and what to do
by: Grazia Fenu, et al.
Published: (2024-06-01)

CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis
by: Kana Yokoyama, et al.
Published: (2022-10-01)

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease
by: Amy Hajari Case
Published: (2022-03-01)

Assessing the diagnostic value of a potential screening tool for detecting early interstitial lung disease at the onset of inflammatory rheumatic diseases
by: Tobias Hoffmann, et al.
Published: (2022-05-01)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
by: Marco Sebastiani, et al.
Published: (2023-11-01)

Are There Differences in Inflammatory and Fibrotic Pathways between IPAF, CTD-ILDs, and IIPs? A Single-Center Pilot Study
by: Patrycja Rzepka-Wrona, et al.
Published: (2022-12-01)

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis
by: Saad Alkhowaiter, et al.
Published: (2024-05-01)

Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
by: Eleanor Valenzi, et al.
Published: (2021-03-01)

Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases
by: Matthias Griese
Published: (2022-03-01)

Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria
by: Francesco Bozzao, et al.
Published: (2023-04-01)

Targeted Therapy in Rheumatoid-Arthritis-Related Interstitial Lung Disease
by: Robert Harrington, et al.
Published: (2023-10-01)

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
by: Minna Mononen, et al.
Published: (2022-08-01)

A Cross-Sectional Survey of Pulmonologists Working at Non-ILD Centers in the United States
by: Biehl R, et al.
Published: (2023-07-01)

Hematopoietic Cell Transplantation for Systemic Sclerosis—A Review
by: Daniel Levin, et al.
Published: (2022-12-01)

Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
by: Matthias Griese, et al.
Published: (2022-07-01)

Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisResearch in context
by: Theresia A. Mikolasch, et al.
Published: (2023-01-01)

Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis
by: Li Xu, et al.
Published: (2021-10-01)

Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study
by: Kyung-In Joung, et al.
Published: (2023-03-01)

Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
by: Vishal Saddi, et al.
Published: (2017-07-01)

Smoking Related Interstitial Lung Disease - High Resolution Computed Tomography (HRCT) findings in 40 smokers
by: Youssriah Yahia Sabri, et al.
Published: (2014-06-01)

A Review of MDA-5 Dermatomyositis and Associated Interstitial Lung Disease
by: Sambhawana Bhandari, et al.
Published: (2024-02-01)

Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
by: Chiara Pellicano, et al.
Published: (2023-02-01)

Risk factors for progression of pulmonary fibrosis: a single-centered, retrospective study
by: Jia-Jia Fan, et al.
Published: (2024-02-01)

Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
by: Azza K. Abdel Megeid, et al.
Published: (2022-08-01)

Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yulu Qiu, et al.
Published: (2024-01-01)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
by: Bergamasco A, et al.
Published: (2019-04-01)

Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay
by: Jun-Jun Yeh, et al.
Published: (2022-05-01)

Correlation of high resolution CT patterns with pulmonary function tests in patients with interstitial lung diseases
by: Khaled Hussein, et al.
Published: (2016-07-01)

High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studiesResearch in context
by: Yehya Al-Adwi, et al.
Published: (2023-12-01)

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
by: Barbara Ruaro, et al.
Published: (2021-10-01)

Utility of selected tumor-associated antigens in systemic sclerosis-related interstitial lung disease – a retrospective single-center study
by: Filip Fijołek, et al.
Published: (2020-10-01)